• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型中 miR-155 和干扰素-γ 信号介导的保护性小胶质细胞状态的鉴定。
Nat Neurosci. 2023 Jul;26(7):1196-1207. doi: 10.1038/s41593-023-01355-y. Epub 2023 Jun 8.
2
Deletion of miR-33, a regulator of the ABCA1-APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice.miR-33 是 ABCA1-APOE 通路的调节因子,其缺失可改善 APP/PS1 小鼠的神经病理表型。
Alzheimers Dement. 2024 Nov;20(11):7805-7818. doi: 10.1002/alz.14243. Epub 2024 Sep 30.
3
PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.PLCG2 与炎症反应有关,并且由阿尔茨海默病中的淀粉样斑块诱导。
Genome Med. 2022 Feb 18;14(1):17. doi: 10.1186/s13073-022-01022-0.
4
CHIT1 regulates the neuroinflammation and phagocytosis of microglia and suppresses Aβ plaque deposition in Alzheimer's disease.几丁质酶1调节小胶质细胞的神经炎症和吞噬作用,并抑制阿尔茨海默病中的β淀粉样蛋白斑块沉积。
J Pathol. 2025 Mar;265(3):330-341. doi: 10.1002/path.6387. Epub 2025 Jan 20.
5
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's disease.通过甘露糖包裹的脂质纳米颗粒靶向抑制小胶质细胞中的 miR-17 改善阿尔茨海默病小鼠模型的病理和行为。
Brain Behav Immun. 2024 Jul;119:919-944. doi: 10.1016/j.bbi.2024.05.006. Epub 2024 May 7.
6
Delphinidin attenuates cognitive deficits and pathology of Alzheimer's disease by preventing microglial senescence via AMPK/SIRT1 pathway.飞燕草素通过AMPK/SIRT1途径预防小胶质细胞衰老,从而减轻阿尔茨海默病的认知缺陷和病理变化。
Alzheimers Res Ther. 2025 Jun 20;17(1):138. doi: 10.1186/s13195-025-01783-x.
7
Amyloid-β plaque-associated microglia drive TSPO upregulation in Alzheimer's disease.淀粉样β蛋白斑块相关的小胶质细胞驱动阿尔茨海默病中转运体蛋白18 kDa(TSPO)的上调。
Acta Neuropathol. 2025 Jul 17;150(1):6. doi: 10.1007/s00401-025-02912-4.
8
DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.DNA低甲基化促进半胱天冬酶-4的表达,这会加剧阿尔茨海默病中的炎症和β-淀粉样蛋白沉积。
Alzheimers Res Ther. 2024 Feb 8;16(1):29. doi: 10.1186/s13195-024-01390-2.
9
Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice.Syndecan-3与β-淀粉样蛋白的共聚集加重5×FAD小鼠的神经炎症和认知障碍。
Int J Mol Sci. 2025 Jun 8;26(12):5502. doi: 10.3390/ijms26125502.
10
PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology.磷脂酶Cγ2(PLCG2)可调节触发受体表达和信号传导,以应对阿尔茨海默病病理变化。
Alzheimers Dement. 2025 May;21(5):e70231. doi: 10.1002/alz.70231.

引用本文的文献

1
The APOE-Microglia Axis in Alzheimer's Disease: Functional Divergence and Therapeutic Perspectives-A Narrative Review.阿尔茨海默病中的载脂蛋白E-小胶质细胞轴:功能差异与治疗前景——一篇叙述性综述
Brain Sci. 2025 Jun 23;15(7):675. doi: 10.3390/brainsci15070675.
2
P2RX7 regulates tauopathy progression via tau and mitochondria loading in extracellular vesicles.P2RX7通过细胞外囊泡中的tau蛋白和线粒体负载来调节tau蛋白病的进展。
Res Sq. 2025 Jun 23:rs.3.rs-6771517. doi: 10.21203/rs.3.rs-6771517/v1.
3
Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions.神经退行性疾病中靶向小胶质细胞的生物标志物与治疗策略:现状与未来方向
Mol Neurodegener. 2025 Jul 10;20(1):82. doi: 10.1186/s13024-025-00867-4.
4
Using RNA therapeutics to promote healthy aging.利用RNA疗法促进健康衰老。
Nat Aging. 2025 Jun;5(6):968-983. doi: 10.1038/s43587-025-00895-1. Epub 2025 Jun 11.
5
Astrocyte induction of disease-associated microglia is suppressed by acute exposure to fAD neurons in human iPSC triple cultures.在人诱导多能干细胞三重培养物中,急性暴露于家族性阿尔茨海默病(fAD)神经元可抑制星形胶质细胞对疾病相关小胶质细胞的诱导作用。
Cell Rep. 2025 Jun 24;44(6):115777. doi: 10.1016/j.celrep.2025.115777. Epub 2025 Jun 3.
6
A spatio-temporal brain miRNA expression atlas identifies sex-independent age-related microglial driven miR-155-5p increase.一份时空脑 miRNA 表达图谱确定了与年龄相关的、性别无关的小胶质细胞驱动的 miR-155-5p 增加。
Nat Commun. 2025 May 17;16(1):4588. doi: 10.1038/s41467-025-59860-6.
7
Targeting ceramide-induced microglial pyroptosis: Icariin is a promising therapy for Alzheimer's disease.靶向神经酰胺诱导的小胶质细胞焦亡:淫羊藿苷是治疗阿尔茨海默病的一种有前景的疗法。
J Pharm Anal. 2025 Apr;15(4):101106. doi: 10.1016/j.jpha.2024.101106. Epub 2024 Sep 19.
8
Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease.免疫检查点TIM-3调节小胶质细胞与阿尔茨海默病。
Nature. 2025 May;641(8063):718-731. doi: 10.1038/s41586-025-08852-z. Epub 2025 Apr 9.
9
MicroRNAs in the biology and hallmarks of neurodegenerative diseases.微小RNA在神经退行性疾病的生物学及特征中的作用
Trends Mol Med. 2025 Apr 7. doi: 10.1016/j.molmed.2025.03.006.
10
A spatio-temporal brain miRNA expression atlas identifies sex-independent age-related microglial driven miR-155-5p increase.一份时空脑 miRNA 表达图谱确定了与性别无关的、年龄相关的小胶质细胞驱动的 miR-155-5p 增加。
bioRxiv. 2025 Mar 16:2025.03.15.643430. doi: 10.1101/2025.03.15.643430.

本文引用的文献

1
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading.慢性 TREM2 激活加剧了 Aβ 相关 tau 种子的形成和传播。
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20220654. Epub 2022 Oct 11.
2
Doublet identification in single-cell sequencing data using .使用. 对单细胞测序数据进行重复鉴定
F1000Res. 2021 Sep 28;10:979. doi: 10.12688/f1000research.73600.2. eCollection 2021.
3
Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells.表达潜伏期相关肽的髓样细胞亚群通过调节T细胞促进癌症生长。
iScience. 2021 Oct 27;24(11):103347. doi: 10.1016/j.isci.2021.103347. eCollection 2021 Nov 19.
4
Integrated analysis of multimodal single-cell data.多模态单细胞数据的综合分析。
Cell. 2021 Jun 24;184(13):3573-3587.e29. doi: 10.1016/j.cell.2021.04.048. Epub 2021 May 31.
5
Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.斑块相关的小胶质细胞过度分泌细胞外囊泡,并加速人源化 APP 小鼠模型中的 tau 传播。
Mol Neurodegener. 2021 Mar 22;16(1):18. doi: 10.1186/s13024-021-00440-9.
6
Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis.时空单细胞 RNA 测序鉴定鸡心脏发育过程中细胞分化和形态发生之间的相互作用。
Nat Commun. 2021 Mar 19;12(1):1771. doi: 10.1038/s41467-021-21892-z.
7
The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid catabolism by microglia.促炎 microRNA miR-155 通过小胶质细胞影响纤维状 β-淀粉样蛋白的代谢。
Glia. 2021 Jul;69(7):1736-1748. doi: 10.1002/glia.23988. Epub 2021 Mar 10.
8
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.阿尔茨海默病中 distinct amyloid-β 和 tau 相关的小胶质细胞特征。
Acta Neuropathol. 2021 May;141(5):681-696. doi: 10.1007/s00401-021-02263-w. Epub 2021 Feb 20.
9
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.预先激活状态塑造了小胶质细胞对阿尔茨海默病小鼠模型中抗人 TREM2 的反应。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2017742118.
10
Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models.新型单克隆抗体与 TREM2 结合可诱导小胶质细胞活化,并改善阿尔茨海默病模型的认知功能。
J Neuroinflammation. 2021 Jan 9;18(1):19. doi: 10.1186/s12974-020-01980-5.

阿尔茨海默病小鼠模型中 miR-155 和干扰素-γ 信号介导的保护性小胶质细胞状态的鉴定。

Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer's disease.

机构信息

Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Nat Neurosci. 2023 Jul;26(7):1196-1207. doi: 10.1038/s41593-023-01355-y. Epub 2023 Jun 8.

DOI:10.1038/s41593-023-01355-y
PMID:37291336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10619638/
Abstract

Microglia play a critical role in brain homeostasis and disease progression. In neurodegenerative conditions, microglia acquire the neurodegenerative phenotype (MGnD), whose function is poorly understood. MicroRNA-155 (miR-155), enriched in immune cells, critically regulates MGnD. However, its role in Alzheimer's disease (AD) pathogenesis remains unclear. Here, we report that microglial deletion of miR-155 induces a pre-MGnD activation state via interferon-γ (IFN-γ) signaling, and blocking IFN-γ signaling attenuates MGnD induction and microglial phagocytosis. Single-cell RNA-sequencing analysis of microglia from an AD mouse model identifies Stat1 and Clec2d as pre-MGnD markers. This phenotypic transition enhances amyloid plaque compaction, reduces dystrophic neurites, attenuates plaque-associated synaptic degradation and improves cognition. Our study demonstrates a miR-155-mediated regulatory mechanism of MGnD and the beneficial role of IFN-γ-responsive pre-MGnD in restricting neurodegenerative pathology and preserving cognitive function in an AD mouse model, highlighting miR-155 and IFN-γ as potential therapeutic targets for AD.

摘要

小胶质细胞在大脑内稳态和疾病进展中发挥着关键作用。在神经退行性疾病中,小胶质细胞获得神经退行性表型(MGnD),但其功能尚未完全阐明。富含于免疫细胞中的 microRNA-155(miR-155)对 MGnD 具有关键的调控作用。然而,其在阿尔茨海默病(AD)发病机制中的作用仍不清楚。本研究报告称,小胶质细胞中 miR-155 的缺失通过干扰素-γ(IFN-γ)信号诱导前 MGnD 激活状态,阻断 IFN-γ 信号可减弱 MGnD 的诱导和小胶质细胞的吞噬作用。AD 小鼠模型中小胶质细胞的单细胞 RNA 测序分析鉴定出 Stat1 和 Clec2d 为前 MGnD 标志物。这种表型转变增强了淀粉样斑块的紧致度,减少了萎缩性神经突,减弱了斑块相关的突触降解,并改善了认知功能。本研究证实了 miR-155 介导的 MGnD 调控机制,以及 IFN-γ 反应性前 MGnD 在限制 AD 小鼠模型中神经退行性病变和保护认知功能方面的有益作用,强调了 miR-155 和 IFN-γ 作为 AD 潜在治疗靶点的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/b19a16875d4d/nihms-1934469-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/2ef46a9417e0/nihms-1934469-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/0dd1aa6c41d4/nihms-1934469-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/2e4fefa5f488/nihms-1934469-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/1cca0248909a/nihms-1934469-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/6456baeb666c/nihms-1934469-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/0c24f91f7f93/nihms-1934469-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/65a49d50c47f/nihms-1934469-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/98f18dcde1c1/nihms-1934469-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/709ad5333933/nihms-1934469-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/36f740dc56f2/nihms-1934469-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/269dd080a17e/nihms-1934469-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/d6ca5da249d0/nihms-1934469-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/4e064c9f0967/nihms-1934469-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/9ed36462fc39/nihms-1934469-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/5a62795835a2/nihms-1934469-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/b19a16875d4d/nihms-1934469-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/2ef46a9417e0/nihms-1934469-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/0dd1aa6c41d4/nihms-1934469-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/2e4fefa5f488/nihms-1934469-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/1cca0248909a/nihms-1934469-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/6456baeb666c/nihms-1934469-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/0c24f91f7f93/nihms-1934469-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/65a49d50c47f/nihms-1934469-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/98f18dcde1c1/nihms-1934469-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/709ad5333933/nihms-1934469-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/36f740dc56f2/nihms-1934469-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/269dd080a17e/nihms-1934469-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/d6ca5da249d0/nihms-1934469-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/4e064c9f0967/nihms-1934469-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/9ed36462fc39/nihms-1934469-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/5a62795835a2/nihms-1934469-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7d/10619638/b19a16875d4d/nihms-1934469-f0006.jpg